Literature DB >> 5559251

Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.

W L Stahl, S M Sumi, P D Swanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5559251     DOI： 10.1111/j.1471-4159.1971.tb11968.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  5 in total

1.  Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.

Authors:  B Lewis; W D Mitchell; C B Marenah; C Cortese; E H Reynolds; R Shakir
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

Review 2.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

3.  Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.

Authors:  Matilde Inglese; Nicola De Stefano; Elisabetta Pagani; Maria T Dotti; Giancarlo Comi; Antonio Federico; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

4.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Emerging cellular themes in leukodystrophies.

Authors:  Joseph C Nowacki; Ashley M Fields; Meng Meng Fu
Journal:  Front Cell Dev Biol       Date:  2022-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.